MiR-125b attenuates human hepatocellular carcinoma malignancy through targeting SIRT6.

Song Shi(Peking University), Jianyuan Luo(Peking University), Miao Yu(Stomatology Hospital), Feng Li(Peking University), Xiaojuan Du(Peking University), Mengmeng Ren(Xi'an Jiaotong University), Boya Liu(Boston Children's Hospital), Junhua Zou(Kunming Medical University), Zhe Wang(Zhongda Hospital Southeast University), Hongquan Zhang(Nanjing University of Posts and Telecommunications), Minghui Liu(Peking University), Hao Qi(Peking University), Yuxia Yang(Peking University), Xin Yang(Peking University)
PubMed
January 1, 2018
Cited by 42


Related Papers